Literature DB >> 11058720

Cholesterol absorption efficiency and sterol metabolism in obesity.

T A Miettinen1, H Gylling.   

Abstract

Role of enterohepatic cholesterol metabolism in obesity-induced increase of cholesterol synthesis was studied in healthy lean (BMI <24) and overweight (BMI >31) subjects by measuring serum lipids (including plant sterols, cholestanol and cholesterol precursors), cholesterol absorption % (double-label method), sterol balance and biliary lipids. New aspects of sterol metabolism in obesity were as follows: low efficiency of cholesterol absorption, reduced ratios to cholesterol of serum and biliary plant sterols and cholestanol (5alpha-derivative of cholesterol), and a marked increase of serum and biliary cholesterol precursor sterols. Percent of cholesterol absorption was positively related to serum cholestanol and plant sterols, and negatively to cholesterol synthesis, measured by the sterol balance technique or cholesterol precursor sterols in serum or bile. Total and endogenous cholesterol fluxes into the intestine were increased, but owing to low absorption percent, mass of cholesterol absorption was within control limits in the obese subjects. Thus, per gram of their large liver tissue the entry of intestinal cholesterol may even be subnormal. Percent of cholesterol absorption was insignificantly negatively (r=-0.256) related to intestinal cholesterol pool, but significantly to biliary concentrations of cholesterol (r=-0.581), bile acids (r=-0.513) and phospholipids (r=-0.469). Thus, dilution of labeled dietary cholesterol by expanded intestinal cholesterol pool could have contributed to subnormal efficiency of cholesterol absorption, or transfer of labeled dietary cholesterol from intestinal oil phase to micellar phase may be competitively inhibited by expanded biliary secretion, resulting in reduced absorption of dietary cholesterol. These mechanisms could have contributed to changes in metabolism of non-cholesterol sterols, especially of cholestanol and plant sterols.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11058720     DOI: 10.1016/s0021-9150(00)00404-4

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  33 in total

1.  Ezetimibe enhances and stabilizes anticoagulant effect of warfarin.

Authors:  Takehiro Hashikata; Minako Yamaoka-Tojo; Ryota Kakizaki; Teruyoshi Nemoto; Kazuhiro Fujiyoshi; Sayaka Namba; Lisa Kitasato; Takuya Hashimoto; Shunsuke Ishii; Ryo Kameda; Takao Shimohama; Taiki Tojo; Junya Ako
Journal:  Heart Vessels       Date:  2016-04-06       Impact factor: 2.037

2.  Plasma sterol evidence for decreased absorption and increased synthesis of cholesterol in insulin resistance and obesity.

Authors:  Pathmaja Paramsothy; Robert H Knopp; Steven E Kahn; Barbara M Retzlaff; Brian Fish; Lina Ma; Richard E Ostlund
Journal:  Am J Clin Nutr       Date:  2011-09-21       Impact factor: 7.045

3.  Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study.

Authors:  Helena Gylling; Maarit Hallikainen; Jussi Pihlajamäki; Piia Simonen; Johanna Kuusisto; Markku Laakso; Tatu A Miettinen
Journal:  J Lipid Res       Date:  2010-05-01       Impact factor: 5.922

Review 4.  Cholesterol absorption: influence of body weight and the role of plant sterols.

Authors:  Helena Gylling; Tatu A Miettinen
Journal:  Curr Atheroscler Rep       Date:  2005-11       Impact factor: 5.113

5.  A Comparison of Metabolic Outcomes Between Obese HIV-Exposed Uninfected Youth From the PHACS SMARTT Study and HIV-Unexposed Youth From the NHANES Study in the United States.

Authors:  Jennifer Jao; Denise L Jacobson; Wendy Yu; William Borkowsky; Mitchell E Geffner; Elizabeth J McFarland; Kunjal Patel; Paige L Williams; Tracie Miller
Journal:  J Acquir Immune Defic Syndr       Date:  2019-07-01       Impact factor: 3.731

6.  Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men.

Authors:  André J Tremblay; Benoît Lamarche; Valéry Lemelin; Lizbeth Hoos; Suzanne Benjannet; Nabil G Seidah; Harry R Davis; Patrick Couture
Journal:  J Lipid Res       Date:  2010-12-01       Impact factor: 5.922

7.  Phytosterol plasma concentrations and coronary heart disease in the prospective Spanish EPIC cohort.

Authors:  Verónica Escurriol; Montserrat Cofán; Concepción Moreno-Iribas; Nerea Larrañaga; Carmen Martínez; Carmen Navarro; Laudina Rodríguez; Carlos A González; Dolores Corella; Emilio Ros
Journal:  J Lipid Res       Date:  2009-09-28       Impact factor: 5.922

8.  Fatty acid- and cholesterol transporter protein expression along the human intestinal tract.

Authors:  Christiaan J Masson; Jogchum Plat; Ronald P Mensink; Andrzej Namiot; Wojciech Kisielewski; Zbigniew Namiot; Joachim Füllekrug; Robert Ehehalt; Jan F C Glatz; Maurice M A L Pelsers
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

9.  A factor model to analyze heterogeneity in gene expression.

Authors:  Yuna Blum; Guillaume Le Mignon; Sandrine Lagarrigue; David Causeur
Journal:  BMC Bioinformatics       Date:  2010-07-02       Impact factor: 3.169

Review 10.  A Systematic Review and Meta-analysis of the Effect of Gastric Bypass Surgery on Plasma Lipid Levels.

Authors:  Kirstin A Carswell; Ajay P Belgaumkar; Stephanie A Amiel; Ameet G Patel
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.